Mr. Guangbo Yu | Artificial Intelligence | Best Researcher Award
Mr .Guangbo Yu, PhD Student, University of California, United States.
Mr. Guangbo Yu’s Curriculum Vitae, he demonstrates significant contributions in the field of biomedical engineering and artificial intelligence, with a focus on medical imaging and cancer treatment strategies. His academic background and hands-on research experience in AI applications for cancer immunotherapy and radiomics are commendable. Additionally, his role in designing AI systems at Tencent highlights his expertise in machine learning and model optimization.
Profile
🎓 Education:
PhD in Biomedical Engineering (Expected 2027)
University of California, Irvine
Specialization: Radiological Science
Advisor: Prof. Zhuoli Zhang
Master’s in Computer Science
University of Southern California (2015–2017)
Bachelor’s in Software Engineering
University of Electronic Science and Technology of China (2011–2015)
🔬 Research Experience:
Graduate Assistant Researcher at UC Irvine (2022–Present)
Focused on using AI for medical imaging to develop predictive models for cancer immunotherapy treatments using MRI biomarkers. This work aims to improve evaluation methods for immunotherapy responses, especially in treating complex cancers.
💼 Professional Experience:
AI Engineer at Tencent QTrade (2020–2022)
Developed an AI-powered system to structure unstructured financial data, using advanced techniques like Named Entity Recognition (NER) with BERT and GAT.
Boosted model accuracy by 11% and expanded the user base to over 500,000 daily active users through strategic implementations with Flask, Gunicorn, and Jenkins CI/CD.
🔍 Research Interests:
Applying AI to enhance cancer immunotherapy strategies, specifically in areas requiring advanced imaging techniques to assess treatment effectiveness.
Citations:
📖 Publications and Presentations:
Qtrade AI at SemEval-2022 Task 11: A Unified Framework for Multilingual NER Task
W. Gan, Y. Lin, G. Yu, G. Chen, & Q. Ye. (2022). Association for Computational Linguistics.
Sorafenib Plus Memory-Like Natural Killer Cell Combination Therapy in Hepatocellular Carcinoma
A. Eresen, Y. Pang, Z. Zhang, Q. Hou, Z. Chen, G. Yu, Y. Wang, V. Yaghmai, … (2024). American Journal of Cancer Research, 14(1), 344.*
Dendritic Cell Vaccination Combined with Irreversible Electroporation for Treating Pancreatic Cancer—A Narrative Review
Z. Zhang, G. Yu, A. Eresen, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). Annals of Translational Medicine.
MRI Radiomics to Monitor Therapeutic Outcome of Sorafenib Plus IHA Transcatheter NK Cell Combination Therapy in Hepatocellular Carcinoma
G. Yu, Z. Zhang, A. Eresen, Q. Hou, E. E. Garcia, Z. Yu, N. Abi-Jaoudeh, … (2024). Journal of Translational Medicine, 22(1), 76.*
Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer
G. Yu, Z. Zhang, A. Eresen, Q. Hou, F. Amirrad, S. Webster, S. Nauli, … (2024). International Journal of Molecular Sciences, 25(22), 12038.*
Sorafenib Plus Memory-Like Natural Killer Cell Immunochemotherapy Boosts Treatment Response in Liver Cancer
A. Eresen, Z. Zhang, G. Yu, Q. Hou, Z. Chen, Z. Yu, V. Yaghmai, Z. Zhang. (2024). BMC Cancer, 24(1), 1215.*
Transcatheter Intraarterial Delivery of Combination Therapy for Hepatocellular Carcinoma
Z. Zhang, A. Eresen, G. Yu, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S199.*
Evaluating Hepatocellular Carcinoma Combination Therapy of Sorafenib and Transcatheter Primed Natural Killer Cell Delivery Using MRI Radiomics Methods
G. Yu, A. Eresen, Z. Zhang, K. Liu, Q. Hou, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S143–S144.*
Improving Therapeutic Response Against Hepatocellular Carcinoma with Cytokine-Activated Natural Killer Cells via Transcatheter Intraarterial Administration
A. Eresen, Z. Zhang, G. Yu, Q. Hou, N. Abi-Jaoudeh, V. Yaghmai. (2024). Journal of Vascular and Interventional Radiology, 35(3), S152.*
Investigation of Natural Killer Cell Delivery in Hepatocellular Carcinoma Treatment with Magnetic Resonance Imaging Radiomics
K. Liu, G. Yu, Z. Zhang, Q. Hou, V. Yaghmai, A. Eresen. (2024). Journal of Vascular and Interventional Radiology, 35(3), S92.*
MRI Monitoring of Combined Therapy with Transcatheter Arterial Delivery of NK Cells and Systemic Administration of Sorafenib for the Treatment of HCC
Z. Zhang, G. Yu, A. Eresen, Q. Hou, V. Yaghmai, Z. Zhang. (2024). American Journal of Cancer Research, 14(5), 2216.*